Total Payments
$162,504
2024 Payments
$64,231
Companies
7
Transactions
105
Medicare Patients
1,394
Medicare Billing
$186,036
Payment Breakdown by Category
Consulting$126,164 (77.6%)
Travel$26,062 (16.0%)
Other$6,451 (4.0%)
Food & Beverage$3,746 (2.3%)
Education$80.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $126,164 | 26 | 77.6% |
| Travel and Lodging | $26,062 | 30 | 16.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,451 | 3 | 4.0% |
| Food and Beverage | $3,746 | 45 | 2.3% |
| Education | $80.81 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $131,162 | 83 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $30,505 | 13 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $325.17 | 4 | $0 (2024) |
| Travere Therapeutics, Inc. | $145.59 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $135.98 | 2 | $0 (2022) |
| GENZYME CORPORATION | $125.04 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $104.88 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64,231 | 33 | Alexion Pharmaceuticals, Inc. ($40,268) |
| 2023 | $70,571 | 31 | Alexion Pharmaceuticals, Inc. ($65,916) |
| 2022 | $10,223 | 19 | Alexion Pharmaceuticals, Inc. ($7,612) |
| 2021 | $900.00 | 2 | Alexion Pharmaceuticals, Inc. ($900.00) |
| 2020 | $5,725 | 3 | Alexion Pharmaceuticals, Inc. ($5,725) |
| 2019 | $10,557 | 14 | Alexion Pharmaceuticals, Inc. ($10,443) |
| 2018 | $117.33 | 1 | Alexion Pharmaceuticals, Inc. ($117.33) |
| 2017 | $180.81 | 2 | Alexion Pharmaceuticals, Inc. ($180.81) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $6,700.00 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $2,680.00 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $6,550.00 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $354.93 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $290.75 | General |
| 10/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $40.53 | General |
| Category: Rare Disease | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $104.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| 09/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $145.59 | General |
| 07/26/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 07/12/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $5,387.00 | General |
| 07/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $225.00 | General |
| 07/12/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $210.90 | General |
| 06/04/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $98.11 | General |
| 05/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $8,700.00 | General |
| Category: Rare Disease | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| 05/14/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $70.73 | General |
| Category: Nephrology | ||||||
| 05/09/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,487.20 | General |
| 05/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $422.21 | General |
| Category: Rare Disease | ||||||
| 05/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Rare Disease | ||||||
| 05/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Rare Disease | ||||||
| 05/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Rare Disease | ||||||
| 05/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Rare Disease | ||||||
| 03/21/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $9,860.00 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 269 | 411 | $187,286 | $34,730 |
| 2022 | 7 | 260 | 434 | $124,344 | $33,419 |
| 2021 | 9 | 380 | 692 | $279,721 | $53,508 |
| 2020 | 10 | 485 | 817 | $369,694 | $64,379 |
Total Patients
1,394
Total Services
2,354
Medicare Billing
$186,036
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 78 | 82 | $43,024 | $8,334 | 19.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 32 | 33 | $26,709 | $3,602 | 13.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 28 | 30 | $3,469 | $2,330 | 67.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 16 | $4,104 | $1,407 | 34.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 27 | 41 | $9,033 | $1,281 | 14.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 16 | 16 | $11,037 | $1,265 | 11.5% |
| 81002 | Urinalysis, manual test | Office | 2020 | 31 | 34 | $544.00 | $110.52 | 20.3% |
About Dr. Anuja Java, MD
Dr. Anuja Java, MD is a Nephrology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1821263559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anuja Java, MD has received a total of $162,504 in payments from pharmaceutical and medical device companies, with $64,231 received in 2024. These payments were reported across 105 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($126,164).
As a Medicare-enrolled provider, Java has provided services to 1,394 Medicare beneficiaries, totaling 2,354 services with total Medicare billing of $186,036. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Saint Louis, MO
- Active Since 04/23/2008
- Last Updated 09/08/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1821263559
Products in Payments
- ULTOMIRIS (Biological) $61,595
- SOLIRIS (Biological) $41,115
- SOLIRIS (Drug) $10,716
- Ultomiris (Drug) $6,625
- TARPEYO (Drug) $325.17
- CABLIVI (Biological) $125.04
- FARXIGA (Drug) $104.88
- LIVTENCITY (Drug) $65.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Saint Louis
Dr. Marcos Rothstein, Md, MD
Nephrology — Payments: $771,005
Nephrology $771,005
Dr. Daniel Coyne, Md, MD
Nephrology — Payments: $322,158
Nephrology $322,158
Dr. Tarek Alhamad, Md, MD
Nephrology — Payments: $237,080
Nephrology $237,080
Krista Lentine, Md,Phd, MD,PHD
Nephrology — Payments: $90,028
Nephrology $90,028
Dr. Tingting Li, Md, MD
Nephrology — Payments: $61,262
Nephrology $61,262
Dr. Thomas Nickolas, Md, MD
Nephrology — Payments: $48,074
Nephrology $48,074